A.C. Leal Ferrero, A. Mendoza Martínez, C.I. Morellón Peña, V. Jiménez Yuste
{"title":"Alteraciones adquiridas de la coagulación","authors":"A.C. Leal Ferrero, A. Mendoza Martínez, C.I. Morellón Peña, V. Jiménez Yuste","doi":"10.1016/j.med.2024.11.012","DOIUrl":null,"url":null,"abstract":"<div><div>Acquired coagulation disorders are those that occur alongside and develop as a part of hematological, neoplastic, autoimmune, cardiovascular, or hepatic diseases; though they can also originate spontaneously. They usually manifest as a deficit of a coagulation factor or as global hemostasis impairment. Given its variable pathophysiology, the clinical phenotype ranges from mild hemorrhagic symptoms to potentially lethal hemorrhagic manifestations. In most situations, treatment involves addressing the underlying medical condition and includes supportive care to prevent or treat hemorrhagic manifestations.</div></div>","PeriodicalId":100912,"journal":{"name":"Medicine - Programa de Formación Médica Continuada Acreditado","volume":"14 22","pages":"Pages 1299-1308"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine - Programa de Formación Médica Continuada Acreditado","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304541224002981","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Acquired coagulation disorders are those that occur alongside and develop as a part of hematological, neoplastic, autoimmune, cardiovascular, or hepatic diseases; though they can also originate spontaneously. They usually manifest as a deficit of a coagulation factor or as global hemostasis impairment. Given its variable pathophysiology, the clinical phenotype ranges from mild hemorrhagic symptoms to potentially lethal hemorrhagic manifestations. In most situations, treatment involves addressing the underlying medical condition and includes supportive care to prevent or treat hemorrhagic manifestations.